Lobular carcinoma in situ (LCIS) is a non-invasive condition that affects the lobules, or milk-producing glands, of the breast. Specifically, when LCIS occurs in the left breast, it can raise concerns and require further evaluation and management.
While LCIS is considered a type of breast cancer, it is important to note that it does not typically invade surrounding breast tissues or spread to other parts of the body. Instead, LCIS is often an incidental finding during routine breast screenings or biopsies.
Here are some key points to understand about lobular carcinoma in situ of the left breast:
It is essential to consult with a healthcare professional to discuss the best management plan for lobular carcinoma in situ of the left breast. Remember, early detection and regular monitoring play a vital role in maintaining breast health and reducing the risk of developing invasive breast cancer.
Lobular carcinoma in situ (LCIS) of the left breast is a non-invasive condition that begins in the milk-producing glands of the breast. While it does not typically develop into invasive breast cancer, it is considered a marker for an increased risk of developing breast cancer in the future. Treatment options for LCI...
To see full information about treatment please Sign up or Log in